Published in Am J Public Health on May 01, 1997
A multilevel analysis of the relationship between institutional and individual racial discrimination and health status. Am J Public Health (2002) 4.17
Ethnicity- and socio-economic status-related stresses in context: an integrative review and conceptual model. J Behav Med (2008) 2.04
Racial discrimination and health among Asian Americans: evidence, assessment, and directions for future research. Epidemiol Rev (2009) 1.95
Psychosocial factors and preterm birth among African American and White women in central North Carolina. Am J Public Health (2004) 1.60
Maternal upward socioeconomic mobility and black-white disparities in infant birthweight. Am J Public Health (2006) 1.60
Closing the Black-White gap in birth outcomes: a life-course approach. Ethn Dis (2010) 1.43
"It's the skin you're in": African-American women talk about their experiences of racism. an exploratory study to develop measures of racism for birth outcome studies. Matern Child Health J (2008) 1.26
Socioeconomic gradients and low birth-weight: empirical and policy considerations. Health Serv Res (2003) 1.22
The social determinants of infant mortality and birth outcomes in Western developed nations: a cross-country systematic review. Int J Environ Res Public Health (2013) 1.19
Neighborhood deprivation and adverse birth outcomes among diverse ethnic groups. Ann Epidemiol (2010) 1.18
Mediators of ethnic-associated differences in infant birth weight. J Urban Health (1999) 1.08
Low birth weight,very low birth weight rates and gestational age-specific birth weight distribution of korean newborn infants. J Korean Med Sci (2005) 0.98
Revisiting the effect of maternal smoking during pregnancy on offspring birthweight: a quasi-experimental sibling analysis in Sweden. PLoS One (2013) 0.92
Stress-induced inflammatory responses in women: effects of race and pregnancy. Psychosom Med (2013) 0.92
A multilevel analysis of the relationship between institutional and individual racial discrimination and health status. Am J Public Health (2008) 0.91
Age differences in health effects of stressors and perceived control among urban African American women. J Urban Health (2005) 0.90
Future directions in research on institutional and interpersonal discrimination and children's health. Am J Public Health (2013) 0.89
Prenatal depression and adverse birth outcomes: an updated systematic review. Matern Child Health J (2015) 0.87
Lower rates of low birthweight and preterm births in the California Black Infant Health Program. J Natl Med Assoc (2004) 0.86
Paternal and maternal influences on differences in birth weight between Europeans and Indians born in the UK. PLoS One (2013) 0.84
Development of prenatal event history calendar for Black women. J Obstet Gynecol Neonatal Nurs (2008) 0.84
The use of psychosocial stress scales in preterm birth research. Am J Obstet Gynecol (2011) 0.84
New Korean reference for birth weight by gestational age and sex: data from the Korean Statistical Information Service (2008-2012). Ann Pediatr Endocrinol Metab (2014) 0.82
The 2007 los angeles mommy and baby study: a multilevel, population-based study of maternal and infant health in los angeles county. Adv Prev Med (2014) 0.81
The effect of birth-weight with genetic susceptibility on depressive symptoms in childhood and adolescence. Eur Child Adolesc Psychiatry (2006) 0.81
Area racism and birth outcomes among Blacks in the United States. Soc Sci Med (2017) 0.75
Development of the Multidimensional Health Locus of Control (MHLC) Scales. Health Educ Monogr (1978) 8.52
Toward a clearer definition of confounding. Am J Epidemiol (1993) 5.61
Racial differences in low birth weight. Trends and risk factors. N Engl J Med (1987) 3.83
Exemplification of a method for scaling life events: the Peri Life Events Scale. J Health Soc Behav (1978) 3.48
Birth weight among women of different ethnic groups. JAMA (1986) 3.47
Measuring social relationships. The Interview Schedule for Social Interaction. Psychol Med (1980) 2.13
Development of a self-administered questionnaire to measure maternal adjustment and maternal attitudes during pregnancy and after delivery. J Psychosom Res (1984) 1.23
Low birth weight: analysis and recommendations. Future Child (1995) 1.14
The reliability and validity of the maternal social support index. Fam Med (1989) 1.04
Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature (1984) 5.85
Mechanism of met oncogene activation. Cell (1986) 4.20
Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci U S A (1987) 3.99
The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet (2000) 3.91
The human met oncogene is related to the tyrosine kinase oncogenes. Nature (1985) 3.46
InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase. Cell (2000) 3.31
Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr Biol (1999) 3.25
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene (2009) 2.86
Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill (2015) 2.77
Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol (1981) 2.74
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol (1992) 2.53
Thematic analysis of the experience of making a decision to place a family member with Alzheimer's disease in a special care unit. Res Nurs Health (2001) 2.49
Novel vertebrate nucleoporins Nup133 and Nup160 play a role in mRNA export. J Cell Biol (2001) 2.35
Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell (2001) 2.26
The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol (2000) 2.07
Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation. Mol Biol Cell (2000) 2.00
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98
Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity. Mol Cell Biol (2000) 1.94
Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol Cell Biol (1991) 1.90
Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J Biol Chem (1995) 1.82
A C. elegans E/Daughterless bHLH protein marks neuronal but not striated muscle development. Development (1997) 1.81
Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases. J Biol Chem (2000) 1.76
A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol (1996) 1.71
From Tpr-Met to Met, tumorigenesis and tubes. Oncogene (2007) 1.69
New genes for male accessory gland proteins in Drosophila melanogaster. Insect Biochem Mol Biol (1997) 1.68
The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol (1999) 1.67
Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. Proc Natl Acad Sci U S A (1988) 1.64
Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol Cell Biol (1993) 1.64
Three additional DNA polymorphisms in the met gene and D7S8 locus: use in prenatal diagnosis of cystic fibrosis. J Pediatr (1987) 1.63
Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Differ (1990) 1.62
Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol (1996) 1.58
Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. Oncogene (1992) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Acute anterior radiculitis associated with West Nile virus infection. J Neurol Neurosurg Psychiatry (2003) 1.55
Activation of the JNK pathway is essential for transformation by the Met oncogene. EMBO J (1997) 1.55
Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study. J Clin Psychiatry (1998) 1.53
Biomarkers in assessing residential insecticide exposures during pregnancy and effects on fetal growth. Toxicol Appl Pharmacol (2005) 1.51
Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer (1997) 1.50
Refined linkage map of chromosome 7 in the region of the cystic fibrosis gene. Am J Hum Genet (1988) 1.48
Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires a functional Grb2 binding site involving tyrosine 1356. J Biol Chem (1997) 1.48
Involvement of hepatocyte growth factor in kidney development. Dev Biol (1994) 1.47
Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol (2002) 1.46
Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease. Ann Thorac Surg (1999) 1.40
Case management model for a community-based multiple sclerosis clinic. Clin Nurse Spec (2000) 1.38
Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ (1993) 1.36
Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers. Lung Cancer (1998) 1.32
Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1. J Biol Chem (1997) 1.30
Pathways downstream of Shc and Grb2 are required for cell transformation by the tpr-Met oncoprotein. J Biol Chem (1996) 1.26
Simple elective cholecystectomy: to drain or not. Am J Surg (1990) 1.25
Nine-year outcome of the Vermont intervention program for low birth weight infants. Pediatrics (1993) 1.24
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Assembly of proteins to postsynaptic densities after transient cerebral ischemia. J Neurosci (1998) 1.22
Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase. Oncogene (1994) 1.21
Changes in the anterior chamber configuration after small-incision cataract surgery with posterior chamber intraocular lens implantation. Am J Ophthalmol (1997) 1.20
TRIM72 negatively regulates myogenesis via targeting insulin receptor substrate-1. Cell Death Differ (2010) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis. J Biol Chem (1994) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Fluorometric determination of adenine and its derivatives by reaction with glyoxal hydrate trimer. Anal Biochem (1972) 1.18
Identification of a new vertebrate nucleoporin, Nup188, with the use of a novel organelle trap assay. Mol Biol Cell (2000) 1.17
A conserved inositol phospholipid binding site within the pleckstrin homology domain of the Gab1 docking protein is required for epithelial morphogenesis. J Biol Chem (1999) 1.17
Sphingosine-1-phosphate phosphohydrolase-1 regulates ER stress-induced autophagy. Cell Death Differ (2010) 1.16
Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. Oncogene (2010) 1.15
Characterization of the rearranged tpr-met oncogene breakpoint. Mol Cell Biol (1987) 1.15
How hosts control worms. Nature (1997) 1.13
Mefloquine induces dose-related neurological effects in a rat model. Antimicrob Agents Chemother (2006) 1.13
DNA damage-dependent and -independent phosphorylation of the hRad9 checkpoint protein. J Biol Chem (2001) 1.12
Enhanced transformation by a plasma membrane-associated met oncoprotein: activation of a phosphoinositide 3'-kinase-dependent autocrine loop involving hyaluronic acid and CD44. Mol Cell Biol (2000) 1.10
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Two-year experience with ureteral stones: extracorporeal shockwave lithotripsy v ureteroscopic manipulation. J Endourol (1998) 1.09
Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor. Oncogene (2001) 1.08
The key components of resistance to Ostertagia circumcincta in lambs. Parasitol Today (1996) 1.08
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells. Gene Ther (2011) 1.06
Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes. Hum Mol Genet (2001) 1.06
A switch from p130Cas/Crk to Gab1/Crk signaling correlates with anchorage independent growth and JNK activation in cells transformed by the Met receptor oncoprotein. Oncogene (2000) 1.06
Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor. Cell Growth Differ (1994) 1.06
Angiogenesis effects of nerve growth factor (NGF) on rat corneas. J Vet Sci (2001) 1.05
Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus. Oncogene (1995) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Branching tubulogenesis but not scatter of madin-darby canine kidney cells requires a functional Grb2 binding site in the Met receptor tyrosine kinase. J Biol Chem (1996) 1.04
Oncogenic activation of tyrosine kinases. Curr Opin Genet Dev (1994) 1.04
Herpes simplex virus sequences involved in the initiation of oncogenic morphological transformation of rat cells are not required for maintenance of the transformed state. J Gen Virol (1985) 1.03
Antibody colocalization microarray: a scalable technology for multiplex protein analysis in complex samples. Mol Cell Proteomics (2011) 1.02
C1qRP is a heavily O-glycosylated cell surface protein involved in the regulation of phagocytic activity. J Immunol (1999) 1.01
Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W). Oncogene (2010) 1.01
Telomere length changes in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant (1999) 1.00
Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. Proc Natl Acad Sci U S A (1994) 1.00
A simplified cystic fibrosis scoring system (a preliminary report). Can Med Assoc J (1971) 1.00
Distribution of 10-formyltetrahydrofolate synthetase in eubacteria. J Bacteriol (1988) 0.99
The MADS-Box factor CeMEF2 is not essential for Caenorhabditis elegans myogenesis and development. Dev Biol (2000) 0.99
Coexistence of weak ferromagnetism and ferroelectricity in the high pressure LiNbO3-type phase of FeTiO3. Phys Rev Lett (2009) 0.99
The met oncogene: a new member of the tyrosine kinase family and a marker for cystic fibrosis. Cold Spring Harb Symp Quant Biol (1986) 0.99
Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA Cell Biol (1994) 0.98
Goya's living skeleton. BMJ (1992) 0.98
Expression of the met receptor tyrosine kinase in muscle progenitor cells in somites and limbs is absent in Splotch mice. Development (1996) 0.98
The receptor tyrosine kinases: role in cancer progression. Surg Oncol Clin N Am (2001) 0.97
Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration. J Vet Pharmacol Ther (1985) 0.97